{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:24:00Z","timestamp":1785378240916,"version":"3.55.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI165079"],"award-info":[{"award-number":["R01AI165079"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-66540-y","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:55:30Z","timestamp":1765616130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["HIV-induced sialoglycans on infected CD4+ T cells promote immune evasion from myeloid cell-mediated killing"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-3466","authenticated-orcid":false,"given":"Shalini","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M. Shamsul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Opeyemi S.","family":"Adeniji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-6775","authenticated-orcid":false,"given":"Lacy M.","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratima","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-1659","authenticated-orcid":false,"given":"Hiroaki","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Danesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2458-8147","authenticated-orcid":false,"given":"Paul W.","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila B.","family":"Giron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-1231","authenticated-orcid":false,"given":"R. Brad","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-4280","authenticated-orcid":false,"given":"Judd F.","family":"Hultquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-4314","authenticated-orcid":false,"given":"Mohamed","family":"Abdel-Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"66540_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/34929","volume":"391","author":"KL Collins","year":"1998","unstructured":"Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. & Baltimore, D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397\u2013401 (1998).","journal-title":"Nature"},{"key":"66540_CR2","doi-asserted-by":"crossref","first-page":"e154422","DOI":"10.1172\/JCI154422","volume":"132","author":"G Duette","year":"2022","unstructured":"Duette, G. et al. The HIV-1 proviral landscape reveals that Nef contributes to HIV-1 persistence in effector memory CD4+ T cells. J. Clin. Invest. 132, e154422 (2022).","journal-title":"J. Clin. Invest."},{"key":"66540_CR3","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/s41586-023-05779-1","volume":"615","author":"YL Li","year":"2023","unstructured":"Li, Y. L. et al. The structural basis for HIV-1 Vif antagonism of human APOBEC3G. Nature 615, 728\u2013733 (2023).","journal-title":"Nature"},{"key":"66540_CR4","doi-asserted-by":"crossref","first-page":"e1000574","DOI":"10.1371\/journal.ppat.1000574","volume":"5","author":"B Mangeat","year":"2009","unstructured":"Mangeat, B. et al. HIV-1 Vpu neutralizes the antiviral factor Tetherin\/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5, e1000574 (2009).","journal-title":"PLoS Pathog."},{"key":"66540_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nm0396-338","volume":"2","author":"O Schwartz","year":"1996","unstructured":"Schwartz, O., Marechal, V., Le Gall, S., Lemonnier, F. & Heard, J. M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2, 338\u2013342 (1996).","journal-title":"Nat. Med."},{"key":"66540_CR6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41577-021-00649-1","volume":"22","author":"NL Board","year":"2022","unstructured":"Board, N. L., Moskovljevic, M., Wu, F., Siliciano, R. F. & Siliciano, J. D. Engaging innate immunity in HIV-1 cure strategies. Nat. Rev. Immunol. 22, 499\u2013512 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"66540_CR7","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/s41591-021-01590-5","volume":"27","author":"SG Deeks","year":"2021","unstructured":"Deeks, S. G. et al. Research priorities for an HIV cure: international AIDS society global scientific strategy 2021. Nat. Med 27, 2085\u20132098 (2021).","journal-title":"Nat. Med"},{"key":"66540_CR8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1126\/science.adk1831","volume":"383","author":"JD Siliciano","year":"2024","unstructured":"Siliciano, J. D. & Siliciano, R. F. HIV cure: The daunting scale of the problem. Science 383, 703\u2013705 (2024).","journal-title":"Science"},{"key":"66540_CR9","volume":"51","author":"AR Ward","year":"2021","unstructured":"Ward, A. R., Mota, T. M. & Jones, R. B. Immunological approaches to HIV cure. Semin Immunol. 51, 101412 (2021).","journal-title":"Semin Immunol."},{"key":"66540_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nchembio.1388","volume":"10","author":"JE Hudak","year":"2014","unstructured":"Hudak, J. E., Canham, S. M. & Bertozzi, C. R. Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat. Chem. Biol. 10, 69\u201375 (2014).","journal-title":"Nat. Chem. Biol."},{"key":"66540_CR11","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1172\/JCI65899","volume":"124","author":"C Jandus","year":"2014","unstructured":"Jandus, C. et al. Interactions between Siglec-7\/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J. Clin. Invest. 124, 1810\u20131820 (2014).","journal-title":"J. Clin. Invest."},{"key":"66540_CR12","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.1409580111","volume":"111","author":"H Laubli","year":"2014","unstructured":"Laubli, H. et al. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc. Natl. Acad. Sci. USA 111, 14211\u201314216 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66540_CR13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nri.2018.3","volume":"18","author":"E RodrIguez","year":"2018","unstructured":"RodrIguez, E., Schetters, S. T. T. & van Kooyk, Y. The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nat. Rev. Immunol. 18, 204\u2013211 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"66540_CR14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41586-019-1456-0","volume":"572","author":"AA Barkal","year":"2019","unstructured":"Barkal, A. A. et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature 572, 392\u2013396 (2019).","journal-title":"Nature"},{"key":"66540_CR15","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1126\/science.1168988","volume":"323","author":"GY Chen","year":"2009","unstructured":"Chen, G. Y., Tang, J., Zheng, P. & Liu, Y. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323, 1722\u20131725 (2009).","journal-title":"Science"},{"key":"66540_CR16","volume":"86","author":"EA Kang","year":"2020","unstructured":"Kang, E. A. et al. Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-kappaB pathway. Int. Immunopharmacol. 86, 106695 (2020).","journal-title":"Int. Immunopharmacol."},{"key":"66540_CR17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00018-019-03288-x","volume":"77","author":"H Laubli","year":"2020","unstructured":"Laubli, H. & Varki, A. Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses. Cell Mol. Life Sci. 77, 593\u2013605 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"66540_CR18","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","volume":"14","author":"MS Macauley","year":"2014","unstructured":"Macauley, M. S., Crocker, P. R. & Paulson, J. C. Siglec-mediated regulation of immune cell function in disease. Nat. Rev. Immunol. 14, 653\u2013666 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"66540_CR19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1146\/annurev-immunol-102419-035900","volume":"38","author":"S Duan","year":"2020","unstructured":"Duan, S. & Paulson, J. C. Siglecs as Immune Cell Checkpoints in Disease. Annu. Rev. Immunol. 38, 365\u2013395 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"66540_CR20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/ni.3552","volume":"17","author":"R Beatson","year":"2016","unstructured":"Beatson, R. et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat. Immunol. 17, 1273\u20131281 (2016).","journal-title":"Nat. Immunol."},{"key":"66540_CR21","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1172\/JCI120612","volume":"128","author":"MA Stanczak","year":"2018","unstructured":"Stanczak, M. A. et al. Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells. J. Clin. Invest. 128, 4912\u20134923 (2018).","journal-title":"J. Clin. Invest."},{"key":"66540_CR22","volume":"11","author":"H Choi","year":"2021","unstructured":"Choi, H. et al. Development of siglec-9 blocking antibody to enhance anti-tumor immunity. Front. Oncol. 11, 778989 (2021).","journal-title":"Front. Oncol."},{"key":"66540_CR23","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1158\/2326-6066.CIR-18-0505","volume":"7","author":"Q Haas","year":"2019","unstructured":"Haas, Q. et al. Siglec-9 Regulates an effector memory CD8(+) T-cell subset that congregates in the melanoma tumor microenvironment. Cancer Immunol. Res. 7, 707\u2013718 (2019).","journal-title":"Cancer Immunol. Res."},{"key":"66540_CR24","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/bloodadvances.2021006805","volume":"6","author":"J Daly","year":"2022","unstructured":"Daly, J. et al. Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell-mediated tumor responses. Blood Adv. 6, 3352\u20133366 (2022).","journal-title":"Blood Adv."},{"key":"66540_CR25","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1073\/pnas.1608069113","volume":"113","author":"H Xiao","year":"2016","unstructured":"Xiao, H., Woods, E. C., Vukojicic, P. & Bertozzi, C. R. Precision glycocalyx editing as a strategy for cancer immunotherapy. Proc. Natl. Acad. Sci. USA 113, 10304\u201310309 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66540_CR26","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","volume":"16","author":"MA Gray","year":"2020","unstructured":"Gray, M. A. et al. Targeted glycan degradation potentiates the anticancer immune response in vivo. Nat. Chem. Biol. 16, 1376\u20131384 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"66540_CR27","doi-asserted-by":"crossref","first-page":"e141965","DOI":"10.1172\/JCI141965","volume":"131","author":"TY Tsai","year":"2021","unstructured":"Tsai, T. Y. et al. SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection. J. Clin. Invest. 131, e141965 (2021).","journal-title":"J. Clin. Invest."},{"key":"66540_CR28","doi-asserted-by":"crossref","first-page":"e2107424118","DOI":"10.1073\/pnas.2107424118","volume":"118","author":"I Ibarlucea-Benitez","year":"2021","unstructured":"Ibarlucea-Benitez, I., Weitzenfeld, P., Smith, P. & Ravetch, J. V. Siglecs-7\/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity. Proc. Natl. Acad. Sci. USA 118, e2107424118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66540_CR29","doi-asserted-by":"crossref","first-page":"e1010034","DOI":"10.1371\/journal.ppat.1010034","volume":"17","author":"OS Adeniji","year":"2021","unstructured":"Adeniji, O. S. et al. Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells. PLoS Pathog. 17, e1010034 (2021).","journal-title":"PLoS Pathog."},{"key":"66540_CR30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fimmu.2018.01124","volume":"9","author":"D Zhao","year":"2018","unstructured":"Zhao, D. et al. Decreased siglec-9 expression on natural killer cell subset associated with persistent HBV replication. Front. Immunol. 9, 1124 (2018).","journal-title":"Front. Immunol."},{"key":"66540_CR31","doi-asserted-by":"crossref","first-page":"e06184","DOI":"10.7554\/eLife.06184","volume":"4","author":"F Schwarz","year":"2015","unstructured":"Schwarz, F. et al. Siglec receptors impact mammalian lifespan by modulating oxidative stress. Elife 4, e06184 (2015).","journal-title":"Elife"},{"key":"66540_CR32","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1080\/22221751.2020.1826361","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. An atlas of immune cell exhaustion in HIV-infected individuals revealed by single-cell transcriptomics. Emerg. Microbes Infect. 9, 2333\u20132347 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"66540_CR33","doi-asserted-by":"crossref","first-page":"e180282","DOI":"10.1172\/JCI180282","volume":"134","author":"RM Wen","year":"2024","unstructured":"Wen, R. M. et al. Sialylated glycoproteins suppress immune cell killing by binding to Siglec-7 and Siglec-9 in prostate cancer. J. Clin. Invest. 134, e180282 (2024).","journal-title":"J. Clin. Invest."},{"key":"66540_CR34","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.3389\/fimmu.2017.02010","volume":"8","author":"A Olvera","year":"2017","unstructured":"Olvera, A. et al. Benzyl-2-acetamido-2-deoxy-alpha-d-galactopyranoside increases human immunodeficiency virus replication and viral outgrowth efficacy in vitro. Front Immunol. 8, 2010 (2017).","journal-title":"Front Immunol."},{"key":"66540_CR35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.virol.2009.03.022","volume":"388","author":"VH Terry","year":"2009","unstructured":"Terry, V. H., Johnston, I. C. & Spina, C. A. CD44 microbeads accelerate HIV-1 infection in T cells. Virology 388, 294\u2013304 (2009).","journal-title":"Virology"},{"key":"66540_CR36","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1126\/science.284.5418.1372","volume":"284","author":"OT Keppler","year":"1999","unstructured":"Keppler, O. T. et al. UDP-GlcNAc 2-epimerase: a regulator of cell surface sialylation. Science 284, 1372\u20131376 (1999).","journal-title":"Science"},{"key":"66540_CR37","unstructured":"Lewis, A. L., Chen, X., Schnaar, R. L. & Varki, A. Sialic acids and other nonulosonic acids. in Essentials of Glycobiology. (2022)."},{"key":"66540_CR38","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00253-012-4040-1","volume":"94","author":"Y Li","year":"2012","unstructured":"Li, Y. & Chen, X. Sialic acid metabolism and sialyltransferases: natural functions and applications. Appl. Microbiol. Biotechnol. 94, 887\u2013905 (2012).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"66540_CR39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10719-008-9162-4","volume":"26","author":"E Tian","year":"2009","unstructured":"Tian, E. & Ten Hagen, K. G. Recent insights into the biological roles of mucin-type O-glycosylation. Glycoconj. J. 26, 325\u2013334 (2009).","journal-title":"Glycoconj. J."},{"key":"66540_CR40","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3390\/cells10051260","volume":"10","author":"A Gonzalez-Gil","year":"2021","unstructured":"Gonzalez-Gil, A. & Schnaar, R. L. Siglec Ligands. Cells 10, 1260 (2021).","journal-title":"Cells"},{"key":"66540_CR41","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/blood-2014-10-602219","volume":"124","author":"C Kellner","year":"2014","unstructured":"Kellner, C. & Peipp, M. Fc-optimized antibodies quickly pull the trigger. Blood 124, 3180\u20133181 (2014).","journal-title":"Blood"},{"key":"66540_CR42","doi-asserted-by":"crossref","DOI":"10.1038\/srep45319","volume":"7","author":"G Dharmadhikari","year":"2017","unstructured":"Dharmadhikari, G. et al. Siglec-7 restores beta-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes. Sci. Rep. 7, 45319 (2017).","journal-title":"Sci. Rep."},{"key":"66540_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06517.x","volume":"1253","author":"A Varki","year":"2012","unstructured":"Varki, A. & Gagneux, P. Multifarious roles of sialic acids in immunity. Ann. N. Y. Acad. Sci. 1253, 16\u201336 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"66540_CR44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.4268","volume":"23","author":"M Caskey","year":"2017","unstructured":"Caskey, M. et al. Antibody 10-1074 suppresses viremia in HIV-1-infected individuals. Nat. Med. 23, 185\u2013191 (2017).","journal-title":"Nat. Med."},{"key":"66540_CR45","first-page":"E3268","volume":"109","author":"H Mouquet","year":"2012","unstructured":"Mouquet, H. et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies. Proc. Natl. Acad. Sci. USA 109, E3268\u2013E3277 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"66540_CR46","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nature12746","volume":"503","author":"M Shingai","year":"2013","unstructured":"Shingai, M. et al. Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia. Nature 503, 277\u2013280 (2013).","journal-title":"Nature"},{"key":"66540_CR47","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1021\/acs.bioconjchem.8b00680","volume":"29","author":"C Yu","year":"2018","unstructured":"Yu, C. et al. Proximity-Induced Site-Specific Antibody Conjugation. Bioconjugate Chem. 29, 3522\u20133526 (2018).","journal-title":"Bioconjugate Chem."},{"key":"66540_CR48","doi-asserted-by":"crossref","first-page":"e20201908","DOI":"10.1084\/jem.20201908","volume":"218","author":"CD McCann","year":"2021","unstructured":"McCann, C. D. et al. A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapies. J. Exp. Med. 218, e20201908 (2021).","journal-title":"J. Exp. Med."},{"key":"66540_CR49","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0198-8859(02)00386-5","volume":"63","author":"C Barrera","year":"2002","unstructured":"Barrera, C., Espejo, R. & Reyes, V. E. Differential glycosylation of MHC class II molecules on gastric epithelial cells: implications in local immune responses. Hum. Immunol. 63, 384\u2013393 (2002).","journal-title":"Hum. Immunol."},{"key":"66540_CR50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00280-010-1477-8","volume":"68","author":"JC de Freitas Junior","year":"2011","unstructured":"de Freitas Junior, J. C. et al. Inhibition of N-linked glycosylation by tunicamycin induces E-cadherin-mediated cell-cell adhesion and inhibits cell proliferation in undifferentiated human colon cancer cells. Cancer Chemother. Pharmacol. 68, 227\u2013238 (2011).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"66540_CR51","doi-asserted-by":"crossref","first-page":"12786","DOI":"10.1074\/jbc.M511702200","volume":"281","author":"P Hu","year":"2006","unstructured":"Hu, P., Berkowitz, P., Madden, V. J. & Rubenstein, D. S. Stabilization of plakoglobin and enhanced keratinocyte cell-cell adhesion by intracellular O-glycosylation. J. Biol. Chem. 281, 12786\u201312791 (2006).","journal-title":"J. Biol. Chem."},{"key":"66540_CR52","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/glycob\/cws112","volume":"22","author":"AV Everest-Dass","year":"2012","unstructured":"Everest-Dass, A. V. et al. Comparative structural analysis of the glycosylation of salivary and buccal cell proteins: innate protection against infection by Candida albicans. Glycobiology 22, 1465\u20131479 (2012).","journal-title":"Glycobiology"},{"key":"66540_CR53","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1038\/s41564-024-01806-7","volume":"9","author":"HL Itell","year":"2024","unstructured":"Itell, H. L., Guenthoer, J., Humes, D., Baumgarten, N. E. & Overbaugh, J. Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1. Nat. Microbiol. 9, 2985\u20132996 (2024).","journal-title":"Nat. Microbiol."},{"key":"66540_CR54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104732","volume":"95","author":"C Duran-Castells","year":"2023","unstructured":"Duran-Castells, C. et al. Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination. EBioMedicine 95, 104732 (2023).","journal-title":"EBioMedicine"},{"key":"66540_CR55","unstructured":"Varki, A., Schnaar, R. L. & Schauer, R. Sialic acids and other nonulosonic acids. in Essentials of Glycobiology (2015)."},{"key":"66540_CR56","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1021\/acscentsci.1c00525","volume":"7","author":"LJ Edgar","year":"2021","unstructured":"Edgar, L. J. et al. Sialic acid ligands of CD28 suppress costimulation of T cells. ACS Cent. Sci. 7, 1508\u20131515 (2021).","journal-title":"ACS Cent. Sci."},{"key":"66540_CR57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/s41392-021-00809-8","volume":"6","author":"Y Gong","year":"2021","unstructured":"Gong, Y., Qin, S., Dai, L. & Tian, Z. The glycosylation in SARS-CoV-2 and its receptor ACE2. Signal Transduct. Target Ther. 6, 396 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"66540_CR58","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.799703","volume":"9","author":"Y Sheng","year":"2022","unstructured":"Sheng, Y. et al. Host cell glycocalyx remodeling reveals SARS-CoV-2 spike protein glycomic binding sites. Front. Mol. Biosci. 9, 799703 (2022).","journal-title":"Front. Mol. Biosci."},{"key":"66540_CR59","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11033-024-09266-2","volume":"51","author":"C Krause","year":"2024","unstructured":"Krause, C., Bergmann, E. & Schmidt, S. V. Epigenetic modulation of myeloid cell functions in HIV and SARS-CoV-2 infection. Mol. Biol. Rep. 51, 342 (2024).","journal-title":"Mol. Biol. Rep."},{"key":"66540_CR60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874613601408010066","volume":"8","author":"V Mehraj","year":"2014","unstructured":"Mehraj, V., Jenabian, M. A., Vyboh, K. & Routy, J. P. Immune suppression by myeloid cells in HIV infection: new targets for immunotherapy. Open AIDS J. 8, 66\u201378 (2014).","journal-title":"Open AIDS J."},{"key":"66540_CR61","doi-asserted-by":"crossref","first-page":"e1012665","DOI":"10.1371\/journal.ppat.1012665","volume":"20","author":"BJ Snow","year":"2024","unstructured":"Snow, B. J. et al. Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells. PLoS Pathog. 20, e1012665 (2024).","journal-title":"PLoS Pathog."},{"key":"66540_CR62","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fimmu.2019.00332","volume":"10","author":"MZ Tay","year":"2019","unstructured":"Tay, M. Z., Wiehe, K. & Pollara, J. Antibody-dependent cellular phagocytosis in antiviral immune responses. Front. Immunol. 10, 332 (2019).","journal-title":"Front. Immunol."},{"key":"66540_CR63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112475","volume":"42","author":"H Egan","year":"2023","unstructured":"Egan, H. et al. Targeting stromal cell sialylation reverses T cell-mediated immunosuppression in the tumor microenvironment. Cell Rep. 42, 112475 (2023).","journal-title":"Cell Rep."},{"key":"66540_CR64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","volume":"4","author":"Y Mei","year":"2023","unstructured":"Mei, Y. et al. Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response. Nat. Cancer 4, 1273\u20131291 (2023).","journal-title":"Nat. Cancer"},{"key":"66540_CR65","volume":"10","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Siglec receptors modulate dendritic cell activation and antigen presentation to T cells in cancer. Front. Cell Dev. Biol. 10, 828916 (2022).","journal-title":"Front. Cell Dev. Biol."},{"key":"66540_CR66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","volume":"14","author":"MA Stanczak","year":"2022","unstructured":"Stanczak, M. A. et al. Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade. Sci. Transl. Med. 14, eabj1270 (2022).","journal-title":"Sci. Transl. Med."},{"key":"66540_CR67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-020-1951-3","volume":"578","author":"CC Nixon","year":"2020","unstructured":"Nixon, C. C. et al. Systemic HIV and SIV latency reversal via non-canonical NF-kappaB signalling in vivo. Nature 578, 160\u2013165 (2020).","journal-title":"Nature"},{"key":"66540_CR68","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107991","volume":"32","author":"F Colomb","year":"2020","unstructured":"Colomb, F. et al. Sialyl-Lewis(X) glycoantigen is enriched on cells with persistent HIV transcription during therapy. Cell Rep. 32, 107991 (2020).","journal-title":"Cell Rep."},{"key":"66540_CR69","doi-asserted-by":"publisher","unstructured":"Le, T. et al. BBrowser: Making single-cell data easily accessible. Preprint at https:\/\/doi.org\/10.1101\/2020.12.11.414136 (2020).","DOI":"10.1101\/2020.12.11.414136"},{"key":"66540_CR70","doi-asserted-by":"publisher","unstructured":"Martinez F. O. Analysis of gene expression and gene silencing in human macrophages.Curr. Protoc. Immunol. https:\/\/doi.org\/10.1002\/0471142735.im1428s96 (2012).","DOI":"10.1002\/0471142735.im1428s96"},{"key":"66540_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"66540_CR72","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 323 (2011).","journal-title":"BMC Bioinform."},{"key":"66540_CR73","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"66540_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41596-018-0069-7","volume":"14","author":"JF Hultquist","year":"2019","unstructured":"Hultquist, J. F. et al. CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions. Nat. Protoc. 14, 1\u201327 (2019).","journal-title":"Nat. Protoc."},{"key":"66540_CR75","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66540-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66540-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T22:02:27Z","timestamp":1767477747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66540-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["66540"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66540-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.F.H. received research support, paid to Northwestern University, from Gilead Sciences and is a paid consultant for Merck and Ridgeback Biotherapeutics. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18"}}